News in the studies of multidrug resistance of breast cancer cells

Breast cancer (BC) is the most common cancer among women in Russia. One of the main treatment methods of BC is systemic chemotherapy. Multidrug resistance of tumor cells (MDR) is the important hindrance on the way to successful chemotherapy. The new data concerning molecular mechanisms of MDR will b...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Stavrovskaya, G. P. Guens
Format: Article
Language:Russian
Published: ABV-press 2015-06-01
Series:Успехи молекулярной онкологии
Subjects:
Online Access:https://umo.abvpress.ru/jour/article/view/4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849688387842211840
author A. A. Stavrovskaya
G. P. Guens
author_facet A. A. Stavrovskaya
G. P. Guens
author_sort A. A. Stavrovskaya
collection DOAJ
description Breast cancer (BC) is the most common cancer among women in Russia. One of the main treatment methods of BC is systemic chemotherapy. Multidrug resistance of tumor cells (MDR) is the important hindrance on the way to successful chemotherapy. The new data concerning molecular mechanisms of MDR will be presented in this review. The recent data concerning some new biological prognostic markers will be also discussed. There are data showing that transporters of ABC family (ABC transporters) influence tumor progression not only by MDR induction but also by the influence on the traits of malignancy in tumor cells. The results of the studies of ABC transporters, participation in the processes of accumulation of tumor stem cells under the influence of chemotherapy will be discussed. The problem of the participation of ABC transporters in the phenomenon of influence of PI3K/AKT/PTEN signal transduction pathway on the MDR regulation is discussed. The results of the studies of the role of microRNA deregulation in breast cancer drug resistance as well as studies of some epigenetic mechanisms of MDR regulation will be considered. Protein phosphatase 2A (PP2A, serine/threonine phosphatase), PTK7 (protein tyrosine kinase 7). fascin (an actin bundling cytoskeletal protein) multifunctional YB-1 protein will considered as new BC prognostic markers. The perspectives of MDR studies will be discussed as well.
format Article
id doaj-art-bf08b8109322425dbefe57830f923239
institution DOAJ
issn 2313-805X
2413-3787
language Russian
publishDate 2015-06-01
publisher ABV-press
record_format Article
series Успехи молекулярной онкологии
spelling doaj-art-bf08b8109322425dbefe57830f9232392025-08-20T03:22:00ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872015-06-012103905110.17650/2313-805X.2015.2.1.039-0514News in the studies of multidrug resistance of breast cancer cellsA. A. Stavrovskaya0G. P. Guens1N.N. Blokhin Russian Cancer Research CenterA. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of RussiaBreast cancer (BC) is the most common cancer among women in Russia. One of the main treatment methods of BC is systemic chemotherapy. Multidrug resistance of tumor cells (MDR) is the important hindrance on the way to successful chemotherapy. The new data concerning molecular mechanisms of MDR will be presented in this review. The recent data concerning some new biological prognostic markers will be also discussed. There are data showing that transporters of ABC family (ABC transporters) influence tumor progression not only by MDR induction but also by the influence on the traits of malignancy in tumor cells. The results of the studies of ABC transporters, participation in the processes of accumulation of tumor stem cells under the influence of chemotherapy will be discussed. The problem of the participation of ABC transporters in the phenomenon of influence of PI3K/AKT/PTEN signal transduction pathway on the MDR regulation is discussed. The results of the studies of the role of microRNA deregulation in breast cancer drug resistance as well as studies of some epigenetic mechanisms of MDR regulation will be considered. Protein phosphatase 2A (PP2A, serine/threonine phosphatase), PTK7 (protein tyrosine kinase 7). fascin (an actin bundling cytoskeletal protein) multifunctional YB-1 protein will considered as new BC prognostic markers. The perspectives of MDR studies will be discussed as well.https://umo.abvpress.ru/jour/article/view/4breast cancertumor progressionmultidrug resistancebiological tumor markerstransporters of abc familytumor stem cells
spellingShingle A. A. Stavrovskaya
G. P. Guens
News in the studies of multidrug resistance of breast cancer cells
Успехи молекулярной онкологии
breast cancer
tumor progression
multidrug resistance
biological tumor markers
transporters of abc family
tumor stem cells
title News in the studies of multidrug resistance of breast cancer cells
title_full News in the studies of multidrug resistance of breast cancer cells
title_fullStr News in the studies of multidrug resistance of breast cancer cells
title_full_unstemmed News in the studies of multidrug resistance of breast cancer cells
title_short News in the studies of multidrug resistance of breast cancer cells
title_sort news in the studies of multidrug resistance of breast cancer cells
topic breast cancer
tumor progression
multidrug resistance
biological tumor markers
transporters of abc family
tumor stem cells
url https://umo.abvpress.ru/jour/article/view/4
work_keys_str_mv AT aastavrovskaya newsinthestudiesofmultidrugresistanceofbreastcancercells
AT gpguens newsinthestudiesofmultidrugresistanceofbreastcancercells